Combined Use of Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma-Reply

Affiliations

Comment

Carlos Gustavo De Moraes et al. JAMA Ophthalmol. 2022.

. 2022 Apr 1;140(4):440-441.

doi: 10.1001/jamaophthalmol.2022.0152.

¹ Bernard and Shirlee Brown Glaucoma Research Laboratory, Department of Ophthalmology, Columbia University Irving Medical Center, New York, New York.

No abstract available

Comment on

Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial.
De Moraes CG, John SWM, Williams PA, Blumberg DM, Cioffi GA, Liebmann JM. De Moraes CG, et al. JAMA Ophthalmol. 2022 Jan 1;140(1):11-18. doi: 10.1001/jamaophthalmol.2021.4576. JAMA Ophthalmol. 2022. PMID: 34792559 Free PMC article.
Combined Use of Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma.
Quah Qin Xian N, Wong FYK. Quah Qin Xian N, et al. JAMA Ophthalmol. 2022 Apr 1;140(4):440. doi: 10.1001/jamaophthalmol.2022.0155. JAMA Ophthalmol. 2022. PMID: 35266978 No abstract available.